We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Breast Cancer Surgery Reduces Risk and Improves Cosmetic Appearance

By HospiMedica International staff writers
Posted on 20 Oct 2008
An innovative procedure for skin-sparing mastectomy (SSM) with immediate breast reconstruction can successfully treat early breast cancer patients while offering favorable aesthetic results.

Researchers at Shinshu University School of Medicine (Matsumoto, Japan carried out the novel endoscopic-assisted technique on 33 patients diagnosed with primary breast cancer between April 2000 and November 2006. More...
The patients subsequently underwent SSM combined with sentinel node biopsy (SNB). On postoperative histopathological diagnosis, 21 tumors were diagnosed as ductal carcinoma in situ or lobular carcinoma in situ. Twelve tumors were diagnosed as invasive carcinoma, of which eight were accompanied by a wide spreading intraductal component. Two patients were diagnosed as having multicentric carcinomas, which made the standard breast-conserving treatment difficult. Immediate breast reconstruction with a mammary prosthesis was carried out in 30 of 33 patients.

The researchers found that after a mean follow-up period of 51.2 months (range 16–86 months), neither locoregional recurrence nor distant metastasis has been detected. The researchers therefore concluded that combining SSM and SNB with immediate reconstruction could offer patients with early-stage breast cancer favorable aesthetic results without incurring additional oncological risks. The study was published in the October 2008 issue of ANZ Journal of Surgery.

"Although breast-conserving surgeries (BCS) are the most desirable choice for patients with early breast cancer, many have to abandon BCS due to tumors accompanied by extended intraductual components or multiple tumors,” said lead author Kenichi Ito, M.D., of the division of breast and endocrine surgery. "With this new technique, selected patients can be treated for breast cancer without breast deformity.”

Related Links:
Shinshu University School of Medicine





Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.